← Eichor
Study identifier: NCT07002034 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Condition: Adjustment Disorder  ·  Sponsor: Reunion Neuroscience Inc

PhasePhase 2
Planned participants100
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms or depressive symptoms mixed with anxiety symptoms in participants with Adjustment Disorder due to cancer or other illnesses such as Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson's Disease (PD) or Idiopathic Pulmonary Fibrosis (IPF) as compared to active-placebo.

This description comes directly from the study's public registry record.

Talk to the study team

Mark Pollack, Chief Medical Officer  ·  1-888-880-REUN  ·  info@reunionneuro.com

Always discuss trial participation with your own doctor first.

Locations (30)

UAB, Psychiatry and Behavioral NeurologyBirmingham, Alabama, United StatesRecruiting
University of ArizonaTucson, Arizona, United StatesRecruiting
Kadima Neuropsychiatry InstituteSan Diego, California, United StatesRecruiting
Providence Medical FoundationSanta Rosa, California, United StatesRecruiting
University of ColoradoAurora, Colorado, United StatesRecruiting
University of South Florida, Department of Psychiatry and Behavioral NeuroscienceTampa, Florida, United StatesRecruiting
Emory UniversityAtlanta, Georgia, United StatesRecruiting
Hawaii Pacific NeuroscienceHonolulu, Hawaii, United StatesRecruiting
Rush University Medical CenterChicago, Illinois, United StatesRecruiting
The University of Kansas Medical CenterKansas City, Kansas, United StatesRecruiting
LSU Health ShreveportShreveport, Louisiana, United StatesRecruiting
Sunstone Therapies, PCRockville, Maryland, United StatesRecruiting

+ 18 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07002034